Abstract:Abstract Background The small number of samples and the curse of dimensionality hamper the better application of deep learning techniques for disease classification. Additionally, the performance of clustering-based feature selection algorithms is still far from being satisfactory due to their limitation in using unsupervised learning methods. To enhance interpretability and overcome this problem, we developed a novel feature selection algorithm. In the meantime, complex genomic data brought great challenges for the identification of biomarkers and therapeutic targets. The current some feature selection methods have the problem of low sensitivity and specificity in this field. Results In this article, we designed a multi-scale clustering-based feature selection algorithm named MCBFS which simultaneously performs feature selection and model learning for genomic data analysis. The experimental results demonstrated that MCBFS is robust and effective by comparing it with seven benchmark and six state-of-the-art supervised methods on eight data sets. The visualization results and the statistical test showed that MCBFS can capture the informative genes and improve the interpretability and visualization of tumor gene expression and single-cell sequencing data. Additionally, we developed a general framework named McbfsNW using gene expression data and protein interaction data to identify robust biomarkers and therapeutic targets for diagnosis and therapy of diseases. The framework incorporates the MCBFS algorithm, network recognition ensemble algorithm and feature selection wrapper. McbfsNW has been applied to the lung adenocarcinoma (LUAD) data sets. The preliminary results demonstrated that higher prediction results can be attained by identified biomarkers on the independent LUAD data set, and we also structured a drug-target network which may be good for LUAD therapy. Conclusions The proposed novel feature selection method is robust and effective for gene selection, classification, and visualization. The framework McbfsNW is practical and helpful for the identification of biomarkers and targets on genomic data. It is believed that the same methods and principles are extensible and applicable to other different kinds of data sets.

DBFE: Distribution-based feature extraction from copy number and structural variants in whole-genome data

DBFE: Distribution-based feature extraction from structural variants in whole-genome data

Copy Number Analysis Of Whole-Genome Data Using Bic-Seq2 And Its Application To Detection Of Cancer Susceptibility Variants

Detection of Copy Number Variants and Loss of Heterozygosity from Impure Tumor Samples Using Whole Exome Sequencing Data.

Copy Number Variation Detection In Whole-Genome Sequencing Data Using The Bayesian Information Criterion

Benchmarking of Germline Copy Number Variant Callers from Whole Genome Sequencing Data for Clinical Applications

Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data

Using the "Hidden" Genome to Improve Classification of Cancer Types

Copynumber: Efficient algorithms for single- and multi-track copy number segmentation

Clonecna: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice

A novel signal processing approach for the detection of copy number variations in the human genome

Integrating Heterogeneous Genomic Data to Accurately Identify Disease Subtypes

Nonparametric Bayesian Knockoff Generators for Feature Selection Under Complex Data Structure

Channel Capacity of Genome-Wide Cell-Free DNA Fragment Length Distribution in Colorectal Cancer

CNVbd: A Method for Copy Number Variation Detection and Boundary Search

Exomehmm: A Hidden Markov Model for Detecting Copy Number Variation Using Whole-Exome Sequencing Data

Classification of Large DNA Methylation Datasets for Identifying Cancer Drivers

FS–GBDT: identification multicancer-risk module via a feature selection algorithm by integrating Fisher score and GBDT

BrcaDx: precise identification of breast cancer from expression data using a minimal set of features

Performance evaluation of DNA copy number segmentation methods